A study conducted in 2019, reported a higher TNBC and HER2 expressing breast cancer specific increased risk in diabetic patients, particularly for TNBC, which expresses higher IGF level [66], along with long-term metformin usage particularly associated with increased odds of developing TNBC. Here, ERBB2 is linked to breast carcinoma.